持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/31 | 3,375 | 3,390 | 3,370 | 3,375 | +15 | +0.4% | 39,600 |
| 2023/08/30 | 3,365 | 3,380 | 3,345 | 3,360 | +20 | +0.6% | 27,800 |
| 2023/08/29 | 3,345 | 3,365 | 3,325 | 3,340 | -5 | -0.1% | 26,400 |
| 2023/08/28 | 3,320 | 3,360 | 3,320 | 3,345 | +30 | +0.9% | 30,000 |
| 2023/08/25 | 3,300 | 3,340 | 3,300 | 3,315 | -5 | -0.2% | 29,200 |
| 2023/08/24 | 3,290 | 3,335 | 3,290 | 3,320 | +30 | +0.9% | 16,200 |
| 2023/08/23 | 3,260 | 3,295 | 3,260 | 3,290 | -10 | -0.3% | 11,700 |
| 2023/08/22 | 3,290 | 3,305 | 3,270 | 3,300 | +30 | +0.9% | 20,900 |
| 2023/08/21 | 3,265 | 3,290 | 3,265 | 3,270 | +25 | +0.8% | 20,900 |
| 2023/08/18 | 3,235 | 3,270 | 3,230 | 3,245 | -5 | -0.2% | 24,700 |
| 2023/08/17 | 3,320 | 3,330 | 3,240 | 3,250 | -95 | -2.8% | 30,800 |
| 2023/08/16 | 3,320 | 3,350 | 3,320 | 3,345 | -5 | -0.1% | 17,800 |
| 2023/08/15 | 3,345 | 3,355 | 3,315 | 3,350 | +5 | +0.1% | 19,500 |
| 2023/08/14 | 3,330 | 3,370 | 3,330 | 3,345 | +15 | +0.5% | 28,400 |
| 2023/08/10 | 3,285 | 3,340 | 3,270 | 3,330 | +45 | +1.4% | 35,700 |
| 2023/08/09 | 3,285 | 3,295 | 3,250 | 3,285 | +10 | +0.3% | 29,800 |
| 2023/08/08 | 3,215 | 3,290 | 3,205 | 3,275 | +100 | +3.1% | 46,900 |
| 2023/08/07 | 3,210 | 3,245 | 3,155 | 3,175 | -20 | -0.6% | 65,900 |
| 2023/08/04 | 3,285 | 3,290 | 3,165 | 3,195 | -95 | -2.9% | 59,000 |
| 2023/08/03 | 3,270 | 3,305 | 3,265 | 3,290 | -25 | -0.8% | 45,200 |
| 2023/08/02 | 3,330 | 3,345 | 3,310 | 3,315 | -30 | -0.9% | 33,500 |
| 2023/08/01 | 3,305 | 3,345 | 3,305 | 3,345 | +40 | +1.2% | 25,900 |
| 2023/07/31 | 3,320 | 3,345 | 3,300 | 3,305 | +20 | +0.6% | 51,400 |
| 2023/07/28 | 3,280 | 3,295 | 3,240 | 3,285 | +5 | +0.2% | 38,600 |
| 2023/07/27 | 3,280 | 3,285 | 3,250 | 3,280 | ±0 | ±0% | 18,600 |
| 2023/07/26 | 3,270 | 3,290 | 3,245 | 3,280 | +40 | +1.2% | 38,400 |
| 2023/07/25 | 3,250 | 3,270 | 3,225 | 3,240 | -15 | -0.5% | 24,900 |
| 2023/07/24 | 3,230 | 3,255 | 3,220 | 3,255 | +40 | +1.2% | 18,400 |
| 2023/07/21 | 3,210 | 3,225 | 3,190 | 3,215 | +25 | +0.8% | 17,500 |
| 2023/07/20 | 3,235 | 3,235 | 3,190 | 3,190 | -35 | -1.1% | 15,800 |
| 2023/07/19 | 3,215 | 3,230 | 3,210 | 3,225 | +25 | +0.8% | 21,600 |
| 2023/07/18 | 3,190 | 3,215 | 3,190 | 3,200 | +15 | +0.5% | 15,300 |
| 2023/07/14 | 3,180 | 3,200 | 3,150 | 3,185 | +15 | +0.5% | 30,700 |
| 2023/07/13 | 3,165 | 3,190 | 3,150 | 3,170 | +5 | +0.2% | 27,700 |
| 2023/07/12 | 3,195 | 3,195 | 3,160 | 3,165 | ±0 | ±0% | 21,800 |
| 2023/07/11 | 3,200 | 3,210 | 3,165 | 3,165 | -35 | -1.1% | 45,500 |
| 2023/07/10 | 3,210 | 3,225 | 3,195 | 3,200 | -10 | -0.3% | 40,100 |
| 2023/07/07 | 3,215 | 3,245 | 3,200 | 3,210 | -30 | -0.9% | 38,700 |
| 2023/07/06 | 3,260 | 3,265 | 3,215 | 3,240 | -20 | -0.6% | 41,000 |
| 2023/07/05 | 3,250 | 3,265 | 3,235 | 3,260 | +5 | +0.2% | 35,100 |
| 2023/07/04 | 3,270 | 3,280 | 3,255 | 3,255 | -45 | -1.4% | 38,400 |
| 2023/07/03 | 3,320 | 3,330 | 3,295 | 3,300 | +10 | +0.3% | 18,600 |
| 2023/06/30 | 3,300 | 3,305 | 3,265 | 3,290 | -20 | -0.6% | 38,500 |
| 2023/06/29 | 3,335 | 3,350 | 3,280 | 3,310 | -15 | -0.5% | 25,100 |
| 2023/06/28 | 3,280 | 3,330 | 3,275 | 3,325 | +50 | +1.5% | 29,600 |
| 2023/06/27 | 3,270 | 3,280 | 3,240 | 3,275 | ±0 | ±0% | 18,600 |
| 2023/06/26 | 3,325 | 3,325 | 3,240 | 3,275 | -15 | -0.5% | 15,800 |
| 2023/06/23 | 3,300 | 3,315 | 3,280 | 3,290 | +5 | +0.2% | 29,900 |
| 2023/06/22 | 3,270 | 3,290 | 3,265 | 3,285 | +25 | +0.8% | 24,700 |
| 2023/06/21 | 3,260 | 3,295 | 3,250 | 3,260 | -5 | -0.2% | 43,600 |
301～
350
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 332,000円 | +3.0% | +27.5% | 2.41% | 21.02倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 285,000円 | +52.1% | +23.3% | 0.00% | 20.23倍 | 3.88倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 466,500円 | +12.0% | +28.1% | 2.57% | 25.71倍 | 1.09倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| ゼリア新薬 | 222,100円 | +13.6% | +29.2% | 2.07% | 11.52倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.47倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
